Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT03523546

Oncology Episode Payment Model in Hawaii

The HMSA Cancer Episode Payment Model (CEM) is a payment model designed to test the effects of better care coordination on health outcomes and costs of care for Hawaii Medical Services Association (HMSA) members with cancer who receive chemotherapy.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Colon Cancer Colonic Diseases Colonic Neoplasms Colorectal Neoplasms Digestive System Diseases Digestive System Neoplasms Gastrointestinal Diseases Gastrointestinal Neoplasms Intestinal Diseases Intestinal Neoplasms Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Skin Diseases Skin and Connective Tissue Diseases Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hawaii Oncology

Honolulu, Hawaii, 96701, United States

About this study

The CEM is designed to improve community health, to improve care coordination, quality, and appropriateness of care, to improve patient experience, and to implement a value-based incentive structure that appropriately rewards oncologists for cost-savings and sustained of improved quality of care.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any oncologist who practices with Hawaii Oncology and is a participating provider.

Exclusion criteria

  • Any provider who does not practice with Hawaii Oncology.

Treatment and study plan

Cancer Episode Payment Model (CEM)

Other

Oncologists will be paid for an episode of care with the opportunity to receive a value based payment based on 6 quality metrics.

Primary outcomes

  1. Composite quality score

    Time frame: 1 year

    Quality metrics included in the oncology model will be compared across the two arms.

  2. Episode cost

    Time frame: 6 months

    Total spending of oncology patients in the episode will be compared across the two arms.

  3. Utilization of acute and specialty care

    Time frame: 6 months

    Total utilization of acute and specialty care of oncology patients in the episode will be compared across the two arms

Secondary outcomes

  1. Quality of care at end of life

    Time frame: 6 months

    Quality measures evaluating use of acute care and palliative care services at the end of life will be compared across the two arms

  2. Survival

    Time frame: one year

    All cause mortality will be compared across the two arms

Sponsors and collaborators

Lead sponsor

University of Pennsylvania

Other

Collaborators

  • Hawaii Medical Service Association

Registry information

Important dates

Study start
2018
Primary completion
2027
Study completion
2028
First posted
May 14, 2018
Registry last updated
Feb 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.